The UK medicines regulator has expanded the use of Pfizer/BioNTech’s COVID-19 vaccine in women who are pregnant and breastfeeding when beneficial, and in people with known allergies. It has also made changes to the vaccine’s dosing interval - allowing a potentially longer time gap between the two doses that need to be administered.
The changes mean even more people are now eligible to receive the Pfizer/BioNTech jab, June Raine, chief executive of the Medicines and Healthcare products Regulatory
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?